Galena Biopharma, Inc. (GALE) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

92% of 12 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Michael_57 Michael_57 04/22/2014 3 months $1.93 $2.28 +18.13% 18 Active
Comments: 30% back for losing 100k is for cry babies law case! This is a grown ups game!
GiselleCH GiselleCH 03/25/2014 3 months $2.70 $2.28 -15.56% -15 Active
Comments:
jrdelane jrdelane 03/25/2014 3 months $2.70 $2.28 -15.56% -15 Active
Comments: After the big bear raid, we still have fundamentals and big upside!
jnlimbachia jnlimbachia 03/18/2014 3 months $2.99 $2.28 -23.75% -23 Active
Comments:
Joward Joward 02/22/2014 1 Year $3.91 $2.28 -41.69% -41 Active
Comments:
villanueva villanueva 02/22/2014 1 Year $3.91 $2.28 -41.69% -41 Active
Comments:
markrefuerzo markrefuerzo 02/20/2014 1 Year $3.91 $2.28 -41.69% -41 Active
Comments:
huongtoan huongtoan 02/14/2014 3 months $3.73 $2.28 -38.87% -38 Active
Comments: I buy gale, because it is a value drug, and now it is cheap, time to buy.
edongzki edongzki 02/11/2014 3 months $5.19 $2.28 -56.07% -56 Active
Comments:
hawksight hawksight 02/05/2014 3 months $4.24 $2.28 -46.23% -46 Active
Comments: Rich Pipeline
noxs4u noxs4u 02/01/2014 3 months $5.27 $2.28 -56.74% 56 Active
Comments: Burn rate on cash vs income
bigcityratt bigcityratt 01/27/2014 1 Year $5.70 $2.28 -60% -60 Active
Comments:
Holstadt d Holbech Holstadt d Holbech 01/06/2014 3 months $5.20 $2.28 -56.15% -56 Ended
Comments:
casey31 casey31 01/01/2014 3 months $4.96 $2.50 -49.6% -49 Ended
Comments: GREAT PIPELINE, PROMISING PHASE 2 TRIAL RESULTS
KARGX KARGX 12/30/2013 3 months $4.82 $2.22 -53.94% -53 Ended
Comments: Upgrades will follow very soon. GALE has Junior Blue Chip potential!
FelixS FelixS 12/27/2013 3 months $4.24 $2.39 -43.63% -43 Ended
Comments: Abstral sales won't disappoint - next target $8 !
chaschee chaschee 11/15/2013 3 months $2.88 $4.34 +50.69% 50 Ended
Comments: strong catalyst,developing pipeline,venture associates,excellent management
Daniel.Caridi Daniel.Caridi 11/13/2013 1 week $3.00 $3.05 +1.67% 1 Ended
Comments:
NicolasCaridi NicolasCaridi 11/13/2013 1 week $3.01 $3.05 +1.33% 1 Ended
Comments: Going Up
prometheusX prometheusX 10/27/2013 3 months $2.23 $5.70 +155.61% 155 Ended
Comments: abstral is out, but once neuvax is approved, this will be the next high-flyer... looking for 10$
Displaying 1-20 of 39
<< first < previous 1 2 next > last >>

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.